* BioRestorative Therapies Inc BRTX.OQ BRTX.O is
expected
to show a fall in quarterly revenue when it reports results on
August 13 for the period ending June 30 2024
* The Melville New York-based company is expected to report
a
76.9% decrease in revenue to $15 thousand from $65 thousand a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for BioRestorative Therapies
Inc
is for a loss of 56 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 2.0%
in the last three months.
* Wall Street's median 12-month price target for
BioRestorative
Therapies Inc is $10.50, above its last closing price
of $1.38.
This summary was machine generated August 7 at 20:29 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)